Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Iscience|October 5, 2021
A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19Friederike Krempe, Lara Schöler, Benjamin Katschinski, et al.Heliyon|January 4, 2023
Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMICaroline Holtkamp, Lara Schöler, Olympia E Anastasiou, et al.Scientific Reports|February 2, 2016
Broad and potent antiviral activity of the NAE inhibitor MLN4924Vu Thuy Khanh Le-Trilling, Dominik A Megger, Benjamin Katschinski, et al.Frontiers in Immunology|January 9, 2019
A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded VpxChristine D Landsberg, Dominik A Megger, Dominik Hotter, et al.Human Immunology|November 5, 2019
HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplantHana Rohn, Esther Schwich, Rafael Tomoya Michita, et al.American Journal of Hematology|January 13, 2021
Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitutionSaskia Leserer, Evren Bayraktar, Mirko Trilling, et al.European Journal of Immunology|October 8, 2020
Prophylactic and therapeutic HBV vaccination by an HBs-expressing cytomegalovirus vector lacking an interferon antagonist in miceHongming Huang, Meike Rückborn, Vu Thuy Khanh Le-Trilling, et al.Human Immunology|March 16, 2023
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patientsHana Rohn, Sabine Schramm, Krystallenia Pansikaki, et al.Elife|July 3, 2025
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAFabienne Maassen, Vu Thuy Khanh Le-Trilling, Luisa Betke, et al.BMJ Open|November 2, 2023
Tiza-<u>T</u>itre <u>i</u>ncrease and enhanced immunity through an adjuvanted, recombinant herpes <u>z</u>oster subunit v<u>a</u>ccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort studyStephanie Vollmer-Raschdorf, Jassin Rashidi-Alavijeh, Sebastian Voigt, et al.Pageof 12